{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:58Z","timestamp":1790959318611,"version":"4.1.0"},"reference-count":73,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,5]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>FOXO3A expression indicates an abortive PC differentiation state in cHL. Tight regulation of FOXO3A is essential for the cHL oncogenic program.<\/jats:p>","DOI":"10.1182\/blood-2017-07-795278","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T21:10:43Z","timestamp":1518556243000},"page":"1556-1567","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation"],"prefix":"10.1182","volume":"131","author":[{"given":"Clarissa D.","family":"Osswald","sequence":"first","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linka","family":"Xie","sequence":"additional","affiliation":[{"name":"Cancer Center of Union Hospital and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfeng","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery of Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Pick","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Gehringer","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Chun","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Centre for Lymphoid Cancers, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Centre for Lymphoid Cancers, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wirth","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Ushmorov","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"23","key":"2019111903534764800_B1","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2012-05-428896","article-title":"Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma","volume":"120","author":"Tiacci","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111903534764800_B2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.191.2.387","article-title":"Rare occurrence of classical Hodgkin\u2019s disease as a T cell lymphoma","volume":"191","author":"M\u00fcschen","year":"2000","journal-title":"J Exp Med"},{"issue":"10","key":"2019111903534764800_B3","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J Clin Invest"},{"issue":"17","key":"2019111903534764800_B4","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2019111903534764800_B5","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111903534764800_B6","first-page":"2080","article-title":"Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells","volume":"61","author":"Re","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"2019111903534764800_B7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni1285","article-title":"Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma","volume":"7","author":"Mathas","year":"2006","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111903534764800_B8","first-page":"701","article-title":"Expression of B-cell antigens by Hodgkin\u2019s and Reed-Sternberg cells","volume":"139","author":"Schmid","year":"1991","journal-title":"Am J Pathol"},{"issue":"11","key":"2019111903534764800_B9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.MP.0000093627.51090.3F","article-title":"Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases","volume":"16","author":"Tzankov","year":"2003","journal-title":"Mod Pathol"},{"issue":"7","key":"2019111903534764800_B10","first-page":"2220","article-title":"Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin\u2019s disease","volume":"92","author":"Carbone","year":"1998","journal-title":"Blood"},{"issue":"9","key":"2019111903534764800_B11","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108.421a21_3108_3113","article-title":"Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin\u2019s disease provides further evidence for its B-cell origin","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"issue":"2","key":"2019111903534764800_B12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2141.2002.03456.x","article-title":"Expression pattern of MUM1\/IRF4 in the spectrum of pathology of Hodgkin\u2019s disease","volume":"117","author":"Carbone","year":"2002","journal-title":"Br J Haematol"},{"issue":"3-4","key":"2019111903534764800_B13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hon.764","article-title":"Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma","volume":"23","author":"Buettner","year":"2005","journal-title":"Hematol Oncol"},{"issue":"6","key":"2019111903534764800_B14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3324\/haematol.2010.031138","article-title":"Classical Hodgkin\u2019s lymphoma shows epigenetic features of abortive plasma cell differentiation","volume":"96","author":"Seitz","year":"2011","journal-title":"Haematologica"},{"issue":"20","key":"2019111903534764800_B15","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood-2014-07-590570","article-title":"FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma","volume":"124","author":"Vogel","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111903534764800_B16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ccr.2010.10.030","article-title":"BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma","volume":"18","author":"Mandelbaum","year":"2010","journal-title":"Cancer Cell"},{"issue":"4","key":"2019111903534764800_B17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200316624","article-title":"Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling","volume":"111","author":"K\u00fcppers","year":"2003","journal-title":"J Clin Invest"},{"issue":"10","key":"2019111903534764800_B18","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"issue":"15","key":"2019111903534764800_B19","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","article-title":"FOXO1 is a tumor suppressor in classical Hodgkin lymphoma","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2019111903534764800_B20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","article-title":"Forkhead-box transcription factors and their role in the immune system","volume":"4","author":"Coffer","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111903534764800_B21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: signalling integrators for homeostasis maintenance","volume":"14","author":"Eijkelenboom","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2019111903534764800_B22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/intimm\/dxp049","article-title":"Foxo3-\/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution","volume":"21","author":"Hinman","year":"2009","journal-title":"Int Immunol"},{"issue":"12","key":"2019111903534764800_B23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ni.1667","article-title":"Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation","volume":"9","author":"Dengler","year":"2008","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111903534764800_B24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1073\/pnas.1017729108","article-title":"14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1","volume":"108","author":"Su","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111903534764800_B25","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.4049\/jimmunol.1103720","article-title":"In vitro generation of long-lived human plasma cells","volume":"189","author":"Cocco","year":"2012","journal-title":"J Immunol"},{"key":"2019111903534764800_B26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fimmu.2013.00460","article-title":"A replicative self-renewal model for long-lived plasma cells: questioning irreversible cell cycle exit","volume":"4","author":"Tooze","year":"2013","journal-title":"Front Immunol"},{"issue":"11","key":"2019111903534764800_B27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.prp.2013.08.003","article-title":"Expression of FoxO3a in clinical cases of malignant lymphoma","volume":"209","author":"Ikeda","year":"2013","journal-title":"Pathol Res Pract"},{"issue":"5","key":"2019111903534764800_B28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3892\/mco.2016.1012","article-title":"ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1 in Hodgkin\u2019s lymphoma","volume":"5","author":"Ikeda","year":"2016","journal-title":"Mol Clin Oncol"},{"issue":"9","key":"2019111903534764800_B29","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-12-256446","article-title":"KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma","volume":"116","author":"Guan","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111903534764800_B30","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/MCB.01662-06","article-title":"Differential regulation of Foxo3a target genes in erythropoiesis","volume":"27","author":"Bakker","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2019111903534764800_B31","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1073\/pnas.96.5.2110","article-title":"Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase\/Akt pathway","volume":"96","author":"Ramaswamy","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111903534764800_B32","volume-title":"Adv Bioinformatics","author":"Hruz","year":"2008"},{"issue":"1","key":"2019111903534764800_B33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2164-12-156","article-title":"RefGenes: identification of reliable and condition specific reference genes for RT-qPCR data normalization","volume":"12","author":"Hruz","year":"2011","journal-title":"BMC Genomics"},{"issue":"1","key":"2019111903534764800_B34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1471-2105-12-474","article-title":"Jetset: selecting the optimal microarray probe set to represent a gene","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"14","key":"2019111903534764800_B35","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.18632\/oncotarget.2107","article-title":"FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma","volume":"5","author":"Xie","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"2019111903534764800_B36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/ard.2009.109991","article-title":"FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue","volume":"69","author":"Turrel-Davin","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"2019111903534764800_B37","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"Jourdan","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111903534764800_B38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.immuni.2015.10.015","article-title":"The FOXO1 transcription factor instructs the Germinal Center Dark Zone Program","volume":"43","author":"Dominguez-Sola","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"2019111903534764800_B39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.immuni.2015.10.021","article-title":"PI3 kinase and FOXO1 transcription factor activity differentially control B cells in the germinal center light and dark zones","volume":"43","author":"Sander","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"2019111903534764800_B40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V68.1.285.bloodjournal681285","article-title":"Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin\u2019s disease","volume":"68","author":"Kamesaki","year":"1986","journal-title":"Blood"},{"issue":"1-2","key":"2019111903534764800_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199309148499","article-title":"Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines","volume":"9","author":"Drexler","year":"1993","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111903534764800_B42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ijc.2910260605","article-title":"Two neoplastic cell lines with unique features derived from Hodgkin\u2019s disease","volume":"26","author":"Schaadt","year":"1980","journal-title":"Int J Cancer"},{"issue":"3-4","key":"2019111903534764800_B43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000112062","article-title":"U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma","volume":"119","author":"Mader","year":"2007","journal-title":"Cytogenet Genome Res"},{"issue":"8","key":"2019111903534764800_B44","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood.V87.8.3429.bloodjournal8783429","article-title":"Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin\/Reed-Sternberg cells of a Hodgkin\u2019s lymphoma patient","volume":"87","author":"Kanzler","year":"1996","journal-title":"Blood"},{"issue":"8","key":"2019111903534764800_B45","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood.V74.8.2733.2733","article-title":"SUP-HD1: a new Hodgkin\u2019s disease-derived cell line with lymphoid features produces interferon-gamma","volume":"74","author":"Naumovski","year":"1989","journal-title":"Blood"},{"issue":"1","key":"2019111903534764800_B46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00405072","article-title":"Hodgkin\u2019s disease: establishment and characterization of four in vitro cell lies","volume":"101","author":"Diehl","year":"1981","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"2019111903534764800_B47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10428190701817282","article-title":"Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2019111903534764800_B48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/cdd.2013.81","article-title":"FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis","volume":"20","author":"van Boxtel","year":"2013","journal-title":"Cell Death Differ"},{"issue":"4","key":"2019111903534764800_B49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni.2242","article-title":"Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile","volume":"13","author":"Oestreich","year":"2012","journal-title":"Nat Immunol"},{"issue":"22","key":"2019111903534764800_B50","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1128\/MCB.24.22.10058-10071.2004","article-title":"FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5\/BCL6-dependent mechanism","volume":"24","author":"Fern\u00e1ndez de Mattos","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2019111903534764800_B51","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/cdd.2011.179","article-title":"FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression","volume":"19","author":"Ferber","year":"2012","journal-title":"Cell Death Differ"},{"issue":"5","key":"2019111903534764800_B52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2010.10.019","article-title":"FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis","volume":"18","author":"Gan","year":"2010","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111903534764800_B53","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3892\/or.2013.2685","article-title":"microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma","volume":"30","author":"Ling","year":"2013","journal-title":"Oncol Rep"},{"issue":"2","key":"2019111903534764800_B54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J Pathol"},{"issue":"8","key":"2019111903534764800_B55","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"Affer","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"2019111903534764800_B56","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.2772","article-title":"\u03b2-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer","volume":"18","author":"Tenbaum","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"2019111903534764800_B57","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2011.08951.x","article-title":"The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival","volume":"156","author":"Obrador-Hevia","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111903534764800_B58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2006.12.029","article-title":"FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis","volume":"128","author":"Paik","year":"2007","journal-title":"Cell"},{"issue":"50","key":"2019111903534764800_B59","doi-asserted-by":"crossref","first-page":"49795","DOI":"10.1074\/jbc.M309523200","article-title":"FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines","volume":"278","author":"Sunters","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111903534764800_B60","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2003-09-3071","article-title":"Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors","volume":"104","author":"Yusuf","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111903534764800_B61","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2353\/ajpath.2010.100089","article-title":"Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines","volume":"177","author":"Ikeda","year":"2010","journal-title":"Am J Pathol"},{"issue":"5","key":"2019111903534764800_B62","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.27748","article-title":"Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation","volume":"132","author":"Frazzi","year":"2013","journal-title":"Int J Cancer"},{"issue":"4","key":"2019111903534764800_B63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(04)00126-6","article-title":"Mammalian SIRT1 represses forkhead transcription factors","volume":"116","author":"Motta","year":"2004","journal-title":"Cell"},{"issue":"18","key":"2019111903534764800_B64","doi-asserted-by":"crossref","first-page":"E2526","DOI":"10.1073\/pnas.1522612113","article-title":"NF-\u03baB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance","volume":"113","author":"Chiu","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111903534764800_B65","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111903534764800_B66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCRESAHA.115.303227","article-title":"FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis","volume":"115","author":"Dharaneeswaran","year":"2014","journal-title":"Circ Res"},{"issue":"4","key":"2019111903534764800_B67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.4062","article-title":"PTEN opposes negative selection and enables oncogenic transformation of pre-B cells","volume":"22","author":"Shojaee","year":"2016","journal-title":"Nat Med"},{"issue":"11","key":"2019111903534764800_B68","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood-2015-01-621623","article-title":"NF-\u03baB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1\/2 expression and activity","volume":"126","author":"Ochodnicka-Mackovicova","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2019111903534764800_B69","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/leu.2016.9","article-title":"Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K\/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition","volume":"30","author":"K\u00f6hrer","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"2019111903534764800_B70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin\u2019s lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2019111903534764800_B71","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.leukres.2009.04.024","article-title":"High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics","volume":"33","author":"Santamar\u00eda","year":"2009","journal-title":"Leuk Res"},{"issue":"5","key":"2019111903534764800_B72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2011.07.032","article-title":"AKT\/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias","volume":"146","author":"Sykes","year":"2011","journal-title":"Cell"},{"issue":"7281","key":"2019111903534764800_B73","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/14\/1556\/1405804\/blood795278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/14\/1556\/1405804\/blood795278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T08:54:43Z","timestamp":1574153683000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/14\/1556\/36665\/Finetuning-of-FOXO3A-in-cHL-as-a-survival"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,5]]},"references-count":73,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,4,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-07-795278","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,5]]}}}